|
|
|
| home > white papers > Exploring Protein Stability by nanoDSF - NanoTemper Technologies GmbH |
|
|
 WHITE PAPERS |
|
NanoTemper Technologies GmbH
|
|
Exploring Protein Stability by nanoDSF
|
|
nanoDSF determines thermal and chemical protein stability with
ultra-high resolution and with unmatched reproducibility. The detection
of the intrinsic tryptophan and tyrosin fluorescence enables
measurements at close-to-native conditions in any buffer, even in the
presence of detergents. nanoDSF is applied in antibody engineering,
membrane protein research, formulation and quality control.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Micro dosing pumps in global use against COVID-19
(PresseBox) ( Schwerin, 24.06.20 ) Automated analysis devices are the
essential basis for extensive test capacities for the corona virus.
Through parallel and faster processes, automation significantly
increases the number of tests, saves manpower and ensures process
reliability. For sample preparation for SARS-CoV-2, a few microliters of
a solution of chemicals and enzymes are dosed. Micro annular gear pumps
of the low pressure series from HNP Mikrosysteme perform this demanding
task with highest precision and process reliability. The minimum dosing
quantity is 0.25 µl, the pumps have a very small footprint and can be
easily integrated into control systems. Fully automated analysis devices
can contain up to sixteen dosing pumps and can handle up to 4,000
samples in 24 hours.
More info >> |
|
 |
White Papers |
 |
|
Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands
West Pharmaceutical Services, Inc.
The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
